Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aerosolized saline refers to a solution of sodium chloride delivered to the respiratory tract via nebulization. It is commonly used in two forms: isotonic (0.9% NaCl), often used as a placebo in clinical trials or for airway humidification, and hypertonic (typically 3% to 7% NaCl). Hypertonic saline acts as a mucoactive agent by creating an osmotic gradient that draws water into the airway lumen, thereby hydrating the mucus, reducing its viscosity, and improving mucociliary clearance. It is a standard supportive therapy for patients with cystic fibrosis and bronchiectasis to facilitate the expectoration of secretions. In clinical research, it is frequently employed as an aerosolized placebo or control intervention to compare against active inhaled medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride (Beth Israel Deaconess Medical Center).